The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Drug Metab Dispos
; 49(3): 276-286, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-33376148
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Berberine
/
Receptors, Cytoplasmic and Nuclear
/
Gluconeogenesis
/
Hypoglycemic Agents
/
Liver
Limits:
Animals
Language:
En
Journal:
Drug Metab Dispos
Journal subject:
FARMACOLOGIA
Year:
2021
Document type:
Article